Number of shares and votes in BioArctic AB (publ) as of August 31, 2026

Rhea-AI Summary

BioArctic (Nasdaq Stockholm: BIOA B) issued 20,200 new Class B shares in August 2026 following the exercise of 20,200 stock options from the 2019/2028 program approved on May 9, 2019. As of August 31, 2026, BioArctic had a total of 88,744,685 shares outstanding, comprising 74,344,689 listed Class B shares and 14,399,996 unlisted Class A shares. Class A shares carry ten votes per share and Class B shares one vote per share, giving a total of 218,344,649 votes in the company.

Market reaction after August share issuance: BIOA -4.15%

-4.15% $9.25

15m delay

-4.15% Vs previous close

$9.25 Last Price

$9.25 $9.80 Day Range

$424.55M Market Cap

0.7x Rel. Volume

Following this news, BIOA has declined 4.15%, reflecting a moderate negative market reaction. Our momentum scanner has triggered 3 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $9.25.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

Only SXTC appeared in the momentum scanner, declining 9.666666388511658%. That limited peer particip...

Analysis

Only SXTC appeared in the momentum scanner, declining 9.666666388511658%. That limited peer participation provides little sector-wide comparison for the share-count update; investors can focus on the issued shares and voting structure disclosed in the announcement.

Key Figures

Class B shares issued: 20,200 shares Stock options exercised: 20,200 options Total shares: 88,744,685 shares +5 more

8 metrics

Class B shares issued 20,200 shares August 2026 stock option exercise

Stock options exercised 20,200 options Series 2019/2028

Total shares 88,744,685 shares As of August 31, 2026

Listed Class B shares 74,344,689 shares As of August 31, 2026

Unlisted Class A shares 14,399,996 shares As of August 31, 2026

Class A voting rights 10 votes per share Share-class voting structure

Class B voting rights 1 vote per share Share-class voting structure

Total votes 218,344,649 votes As of August 31, 2026

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

STOCKHOLM, Aug. 31, 2026 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company issued 20,200 Class B shares during August for delivery of shares to participants in the 2019/2028 stock option program resolved at the Annual General Meeting on May 9, 2019. The shares were issued through an exercise of 20,200 stock options of series 2019/2028.

As of August 31, 2026, the last trading day of the month, the total number of shares in BioArctic AB amounted to 88,744,685 shares, of which 74,344,689 listed Class B shares and 14,399,996 unlisted Class A shares. The A share has ten votes per share and the B share has one vote per share. The total number of votes in the company amounts to 218,344,649.

This information is information that BioArctic is obliged to make public pursuant to the Financial Instruments Trading Act. The information was released for public disclosure, through the agency of the contact persons below, on August 31, 2026, at 5:30pm CEST.

About BioArctic AB
BioArctic AB (publ) is a Swedish research-based biopharma company focusing on innovative treatments that can delay or stop the progression of neurodegenerative diseases. The company invented Leqembi® (lecanemab) – the world's first drug proven to slow the progression of the disease and reduce cognitive impairment in early Alzheimer's disease. Leqembi has been developed together with BioArctic's partner Eisai, who are responsible for regulatory interactions and commercialization globally. In addition to Leqembi, BioArctic has a broad research portfolio with antibodies against Parkinson's disease and ALS as well as additional projects against Alzheimer's disease. Several of the projects utilize the company's proprietary BrainTransporter™ technology, which has the potential to actively transport antibodies across the blood-brain barrier to enhance the efficacy of the treatment. BioArctic's B share (BIOA B) is listed on Nasdaq Stockholm Large Cap. For further information, please visit www.bioarctic.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bioarctic/r/number-of-shares-and-votes-in-bioarctic-ab--publ--as-of-august-31--2026,c4390086

The following files are available for download:

https://mb.cision.com/Main/9978/4390086/4243546.pdf

​​​​​​​Number of shares and votes in BioArctic AB (publ) as of August 31, 2026

For further information, please contact: 
Oskar Bosson, VP Communications and Investor Relations
E-mail: oskar.bosson@bioarctic.com
Telephone: +46 704 107 180

Jenny Ljunggren, External Communications and Investor Relations Manager
E-mail: jenny.ljunggren@bioarctic.com
Telephone: +46 76 013 86 08

View original content:https://www.prnewswire.com/news-releases/number-of-shares-and-votes-in-bioarctic-ab-publ-as-of-august-31-2026-302865115.html

SOURCE BioArctic

FAQ

How many shares does BioArctic (BIOA B) have outstanding as of August 31, 2026?

BioArctic reports a total of 88,744,685 shares outstanding as of August 31, 2026. According to BioArctic, this consists of 74,344,689 listed Class B shares and 14,399,996 unlisted Class A shares after August’s option exercises.

How many new BioArctic (BIOA B) shares were issued in August 2026?

BioArctic issued 20,200 new Class B shares in August 2026. According to BioArctic, these shares were created through the exercise of 20,200 stock options from the 2019/2028 incentive program approved at the 2019 Annual General Meeting.

What is the total number of votes in BioArctic (BIOA B) as of August 31, 2026?

BioArctic reports a total of 218,344,649 votes as of August 31, 2026. According to BioArctic, each Class A share carries ten votes and each Class B share one vote, reflecting the company’s dual-share structure.

What is the difference between BioArctic’s Class A and Class B shares as of August 31, 2026?

The key difference is voting power: Class A has ten votes, Class B has one. According to BioArctic, there are 14,399,996 unlisted Class A shares and 74,344,689 listed Class B shares, together totaling 218,344,649 votes on that date.

Which stock option program led to new BioArctic (BIOA B) shares in August 2026?

The new shares came from the 2019/2028 stock option program. According to BioArctic, 20,200 options from this program, approved at the May 9, 2019 Annual General Meeting, were exercised, resulting in issuance of 20,200 Class B shares.